EUVIMEDEUVIMED entdecken
Crossref

Is Bone Marrow Trephine Biopsy Necessary in Multiple Myeloma Patients at Diagnosis?

Ana Gea, Tatiana Fernández, Sara Fernández-Luis, Juan J Domínguez-García, Irene Francés, Ana Tobalina, Rodrigo Cantera, Julia Bannatyne, Irene Gorostidi, María Oviedo, Juan M Cerezo, Raquel García und 6 weitere

Clinical Lymphoma Myeloma and Leukemia · 2025

DOI: 10.1016/j.clml.2024.12.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Ana Gea und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Hospital Marqués de Valdecilla/IDIVAL, Santander, Spain. Hauptthemen laut MEDLINE: Multiple Myeloma, Bone Marrow. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) diagnosis requires ≥10% plasma cell (PC) infiltration in the bone marrow (BM), detected by bone marrow aspiration (BMA) or biopsy (BMB). We evaluated the concordance of these 2 techniques in 189 patients. In 43 cases (23%), the techniques were discordant, 10 due to poor sample quality. In the remaining 33 patients, BMB diagnosed MM, while BMA detected < 10% PC, being symptomatic in 16 patients and smouldering (SMM) in 17. Without an initial BMB, 11% would have been misdiagnosed; and 12% of symptomatic patients would require a second BMA or BMB for strict diagnosis according to current criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaBone MarrowHumansMaleFemaleAgedMiddle AgedBiopsyAged, 80 and overAdult

Stichwörter der Autor:innen

AspirateBone marrowInfiltrationMultiple myelomaTrephine biopsy

Autor:innen und Institutionen

  • Department of Hematology, University Hospital Marqués de Valdecilla/IDIVAL, Santander, Spain.
  • Department of Hematology, University Hospital Marqués de Valdecilla/IDIVAL, Santander, Spain; University of Cantabria, Santander, Spain.
  • Department of Pathology and Translational Hematopathology Laboratory, University Hospital Marqués de Valdecilla/IDIVAL, Santander, Spain; University of Cantabria, Santander, Spain.
  • Department of Hematology, University Hospital Marqués de Valdecilla/IDIVAL, Santander, Spain; University of Cantabria, Santander, Spain. Electronic address: ocioem@unican.es.

Zitieren

APA

Gea, A., Fernández, T., Fernández-Luis, S., Domínguez-García, J. J., Francés, I., Tobalina, A., Cantera, R., Bannatyne, J., Gorostidi, I., Oviedo, M., Cerezo, J. M., García, R., Insunza, A., Montes-Gaisán, C., Bermúdez, A., Montes-Moreno, S., Briz, M., & Ocio, E. M. (2025). Is Bone Marrow Trephine Biopsy Necessary in Multiple Myeloma Patients at Diagnosis?. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.12.004

Vancouver

Gea A, Fernández T, Fernández-Luis S, Domínguez-García JJ, Francés I, Tobalina A, et al. Is Bone Marrow Trephine Biopsy Necessary in Multiple Myeloma Patients at Diagnosis?. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2024.12.004

BibTeX
@article{Gea2025,
  author = {Gea, Ana and Fernández, Tatiana and Fernández-Luis, Sara and Domínguez-García, Juan J and Francés, Irene and Tobalina, Ana and Cantera, Rodrigo and Bannatyne, Julia and Gorostidi, Irene and Oviedo, María and Cerezo, Juan M and García, Raquel and Insunza, Andrés and Montes-Gaisán, Carmen and Bermúdez, Aránzazu and Montes-Moreno, Santiago and Briz, Montserrat and Ocio, Enrique M},
  title = {Is Bone Marrow Trephine Biopsy Necessary in Multiple Myeloma Patients at Diagnosis?},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2025},
  doi = {10.1016/j.clml.2024.12.004}
}
Kostenlos starten →